• $22.7M
    Market Cap
  • -61.53%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-12.6M
-55.73%
-28.5M
+62.74%
-17.5M
-22.32%
-22.5M
+31.23%
Depreciation and Amortization Expense
266,000
-31.62%
389,000
+2.10%
381,000
-40.28%
638,000
+70.59%
Total Operating Expenses
14.0M
+3.09%
13.6M
+16.22%
11.7M
-3.75%
12.1M
+23.35%
Operating Profit
-26.6M
-36.77%
-42.0M
+44.14%
-29.2M
-15.83%
-34.6M
+28.36%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-207,000
-84.27%
-1.3M
-9.18%
-1.4M
-10.44%
-1.6M
+26.21%
Interest Income and Expense and Net
-207,000
-84.27%
-1.3M
-9.18%
-1.4M
-10.44%
-1.6M
+26.21%
Total Nonoperating Income and Expense
313,000
+71.04%
183,000
+154.79%
-334,000
-68.76%
-1.1M
-18.77%
Income before Taxes
-26.6M
-36.77%
-42.0M
+44.14%
-29.2M
-15.83%
-34.6M
+28.36%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-26.3M
-37.24%
-41.8M
+41.88%
-29.5M
-17.41%
-35.7M
+26.17%
Net Income from Continuing Operations Applicable to Common
-26.3M
-37.24%
-41.8M
+41.88%
-29.5M
-17.41%
-35.7M
+26.17%
Basic EPS and Net Income
-6.33
+322.00%
-1.50
-21.47%
-1.91
-38.19%
-3.09
-58.63%
Diluted EPS and Net Income
-6.33
+322.00%
-1.50
-21.47%
-1.91
-38.19%
-3.09
-58.63%
Basic Weighted Average Shares
4.1M
-85.13%
27.9M
+80.99%
15.4M
+33.49%
11.5M
+204.70%
Diluted Weighted Average Shares
4.1M
-85.13%
27.9M
+80.99%
15.4M
+33.49%
11.5M
+204.70%
Balance Sheet
Cash and Cash Equivalents
7.7M
-74.54%
30.3M
-22.84%
39.2M
+25.62%
31.2M
-39.74%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.7M
-74.54%
30.3M
-22.84%
39.2M
+25.62%
31.2M
-39.74%
Total Current Assets
8.3M
-73.73%
31.5M
-22.02%
40.4M
+22.50%
33.0M
-52.22%
Accumulated Depreciation
1.5M
+10.08%
1.3M
+28.78%
1.0M
-24.69%
1.4M
+65.17%
Property and Plant and Equipment and Net
605,000
-31.72%
886,000
+5.48%
840,000
-20.75%
1.1M
-4.76%
Total Long-Term Assets
517,000
+6.60%
485,000
+8.26%
448,000
+4.43%
429,000
+286.49%
Total Assets
16.9M
-59.19%
41.5M
-19.60%
51.6M
+11.96%
46.1M
-37.07%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
0
-100.00%
6.4M
+48.28%
4.3M
N/A
N/A
N/A
Total Current Liabilities
3.3M
-76.69%
14.2M
+51.10%
9.4M
+29.33%
7.3M
-63.66%
Total Long-Term Debt
N/A
N/A
0
-100.00%
6.3M
-39.60%
10.4M
-31.18%
Total Long-Term Liabilities
6.9M
-14.65%
8.1M
-47.21%
15.4M
-25.49%
20.7M
+21.09%
Total Liabilities
10.3M
-54.11%
22.4M
-9.96%
24.8M
-11.23%
28.0M
-24.63%
Retained Earnings
-233.4M
+12.68%
-207.1M
+25.32%
-165.3M
+21.72%
-135.8M
+35.69%
Total Stockholders Equity
6.7M
-65.14%
19.1M
-28.55%
26.8M
+47.80%
18.1M
-49.85%
Total Shares Outstanding
4.9M
-88.79%
44.0M
+99.46%
22.0M
+109.58%
10.5M
+52.21%
Cash Flow
Cash from Operating Activities
-26.8M
-18.79%
-33.0M
+20.73%
-27.4M
-11.96%
-31.1M
+19.71%
Capital Expenditures
0
-100.00%
435,000
+155.88%
170,000
-69.75%
562,000
+316.30%
Cash from Investing Activities
0
+100.00%
-435,000
+155.88%
-170,000
-69.75%
-562,000
+479.38%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4.3M
-82.62%
24.5M
-31.18%
35.6M
+212.22%
11.4M
-80.69%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-89.91%
+0.01%
-89.90%
+48.90%
-60.38%
+0.88%
-59.85%
+23.34%
Return on Equity
-203.63%
+11.67%
-182.35%
+38.75%
-131.42%
-0.21%
-131.70%
+60.95%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.50
+12.73%
2.21
-48.39%
4.29
-5.28%
4.53
+31.49%
Cash Ratio
2.33
+9.25%
2.13
-48.94%
4.17
-2.87%
4.29
+65.82%
Debt-to-Equity Ratio
N/A
N/A
0.33
-15.71%
0.39
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
0.15
-25.05%
0.20
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow